Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 2
1998 3
2001 19
2002 71
2003 115
2004 280
2005 416
2006 654
2007 949
2008 1122
2009 1235
2010 1205
2011 1332
2012 1313
2013 1391
2014 1393
2015 1449
2016 1581
2017 1488
2018 1298
2019 1202
2020 1328
2021 1144
2022 974
2023 816
2024 794
2025 854
2026 709

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,993 results

Results by year

Filters applied: . Clear all
Page 1
Drug-eluting stent thrombosis: current and future perspectives.
Kuramitsu S, Sonoda S, Ando K, Otake H, Natsuaki M, Anai R, Honda Y, Kadota K, Kobayashi Y, Kimura T. Kuramitsu S, et al. Cardiovasc Interv Ther. 2021 Apr;36(2):158-168. doi: 10.1007/s12928-021-00754-x. Epub 2021 Jan 13. Cardiovasc Interv Ther. 2021. PMID: 33439454 Review.
Over the past 40 years, the safety and efficacy of percutaneous coronary intervention has dramatically improved by overcoming several challenges. The introduction of drug-eluting stent (DES) in particular was a major breakthrough in interventional cardiology. …
Over the past 40 years, the safety and efficacy of percutaneous coronary intervention has dramatically improved by overcoming several challe …
Intravascular ultrasound-guided drug-eluting stent implantation.
Shlofmitz E, Kuku KO, Waksman R, Garcia-Garcia HM. Shlofmitz E, et al. Minerva Cardioangiol. 2019 Aug;67(4):306-317. doi: 10.23736/S0026-4725.19.04895-3. Epub 2019 Mar 4. Minerva Cardioangiol. 2019. PMID: 30845795 Review.
Real-time online analysis with IVUS allows determination of lumen and vessel size, guiding appropriate stent selection. Following stent implantation, IVUS can assess for parameters that include stent malapposition, underexpansion, and stent edge compli …
Real-time online analysis with IVUS allows determination of lumen and vessel size, guiding appropriate stent selection. Following …
Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge.
Donisan T, Madanat L, Balanescu DV, Mertens A, Dixon S. Donisan T, et al. Curr Cardiol Rev. 2023;19(3):e030123212355. doi: 10.2174/1573403X19666230103154638. Curr Cardiol Rev. 2023. PMID: 36597603 Free PMC article. Review.
Although rates of ISR have decreased in most recent years owing to newer generation drug-eluting stents, thinner struts, and better intravascular imaging modalities, ISR remains a prevalent dilemma that proves to be challenging to manage. Several factors have …
Although rates of ISR have decreased in most recent years owing to newer generation drug-eluting stents, thinner struts …
Drug-eluting stent safety.
Slottow TL, Waksman R. Slottow TL, et al. Am J Cardiol. 2007 Oct 22;100(8B):10M-17M. doi: 10.1016/j.amjcard.2007.08.017. Am J Cardiol. 2007. PMID: 17950827 Review.
Drug-eluting stents (DESs) held the promise of mitigating, if not abolishing, in-stent restenosis. ...The risk for stent thrombosis after bare metal stent placement appears to diminish with time, while very late stent thrombosis (& …
Drug-eluting stents (DESs) held the promise of mitigating, if not abolishing, in-stent restenosis. ...The risk f …
Coronary In-Stent Restenosis: JACC State-of-the-Art Review.
Giustino G, Colombo A, Camaj A, Yasumura K, Mehran R, Stone GW, Kini A, Sharma SK. Giustino G, et al. J Am Coll Cardiol. 2022 Jul 26;80(4):348-372. doi: 10.1016/j.jacc.2022.05.017. J Am Coll Cardiol. 2022. PMID: 35863852 Free article. Review.
The introduction and subsequent iterations of drug-eluting stent technologies have substantially improved the efficacy and safety of percutaneous coronary interventions. ...Given that millions of drug-eluting stents are implanted each yea …
The introduction and subsequent iterations of drug-eluting stent technologies have substantially improved the efficacy …
Drug eluting stent in urology.
Kallidonis P, Ntasiotis P, Kamal W, Kyriazis I, Liatsikos E. Kallidonis P, et al. Arch Esp Urol. 2016 Oct;69(8):595-600. Arch Esp Urol. 2016. PMID: 27725335 Review. English.
The Drug eluting stents (DESs) are the most commonly used stents in interventional cardiology. ...Urological stents are important instruments of the everyday urological practice with a variety of indications for their use. ...
The Drug eluting stents (DESs) are the most commonly used stents in interventional cardiology. ...Urological …
Drug-eluting stent thrombosis.
Pilgrim T, Windecker S. Pilgrim T, et al. Minerva Cardioangiol. 2009 Oct;57(5):611-20. Minerva Cardioangiol. 2009. PMID: 19838151
Drug-eluting stents (DES) have reduced the risk of repeat revascularization procedures by 50-70% compared with bare metal stents across a wide range of lesion and patients subsets. ...Although stent thrombosis has been recognized as a shortcomin …
Drug-eluting stents (DES) have reduced the risk of repeat revascularization procedures by 50-70% compared with bare met …
Drug-eluting stent fracture: incidence, contributing factors, and clinical implications.
Canan T, Lee MS. Canan T, et al. Catheter Cardiovasc Interv. 2010 Feb 1;75(2):237-45. doi: 10.1002/ccd.22212. Catheter Cardiovasc Interv. 2010. PMID: 20025045 Review.
Since the introduction of drug-eluting stents, stent fractures have also been reported in small studies and case reports. We reviewed these publications to assess what is known regarding the incidence, contributing factors, and clinical implications of …
Since the introduction of drug-eluting stents, stent fractures have also been reported in small studies and case …
Recurrent drug eluting stent, in-stent restenosis (DES-ISR): Epidemiology, pathophysiology & treatment.
Gupta A, Maitas O, Patel RAG. Gupta A, et al. Prog Cardiovasc Dis. 2025 Jan-Feb;88:68-74. doi: 10.1016/j.pcad.2024.12.003. Epub 2025 Jan 3. Prog Cardiovasc Dis. 2025. PMID: 39755191 Review.
Coronary artery in-stent restenosis (ISR) is driven by neointimal hyperplasia and neo-atherosclerosis in previously placed stents. Drug eluting stents (DES) have been adopted as first line therapy for the initial episode of ISR. ...
Coronary artery in-stent restenosis (ISR) is driven by neointimal hyperplasia and neo-atherosclerosis in previously placed stents …
21,993 results
You have reached the last available page of results. Please see the User Guide for more information.